Natriuretic peptides in relation to the cardiac innervation and conduction system

✍ Scribed by Magnus Hansson

• Publisher: John Wiley and Sons
• Year: 2002
• Tongue: English
• Weight: 89 KB
• Volume: 58
• Category: Article
• ISSN: 1059-910X
• DOI: 10.1002/jemt.10158

✦ Synopsis

Abstract

During the past two decades, the heart has been known to undergo endocrine action, harbouring peptides with hormonal activities. These, termed “atrial natriuretic peptide (ANP),” “brain natriuretic peptide (BNP),” and “C‐type natriuretic peptide (CNP),” are polypeptides mainly produced in the cardiac myocardium, where they are released into the circulation, producing profound hypotensive effects due to their diuretic, natriuretic, and vascular dilatory properties. It is, furthermore, well established that cardiac disorders such as congestive heart failure and different forms of cardiomyopathy are combined with increased expression of ANP and BNP, leading to elevated levels of these peptides in the plasma. Besides the occurrence of natriuretic peptides (NPs) in the ordinary myocardium, the presence of ANP in the cardiac conduction system has been described. There is also evidence of ANP gene expression in nervous tissue such as the nodose ganglion and the superior cervical ganglion of the rat, ganglia known to be involved in the neuronal regulation of the heart. Furthermore, in the mammalian heart, ANP appears to affect the cardiac autonomic nervous system by sympathoinhibitory and vagoexcitatory actions. This article provides an overview of the relationship between the cardiac conduction system, the cardiac innervation and NPs in the mammalian heart and provides data for the concept that ANP is also involved in neuronal cardiac regulation. Microsc. Res. Tech. 58:378–386, 2002. © 2002 Wiley‐Liss, Inc.